Ultragenyx Pharmaceutical Inc. (RARE)
USD 39.3
(0.85%)
USD 39.3
(0.85%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.21 Billion USD | 1.9% |
| 2022 | 1.19 Billion USD | 98.88% |
| 2021 | 599.83 Million USD | -0.88% |
| 2020 | 605.18 Million USD | 25.63% |
| 2019 | 481.73 Million USD | 335.37% |
| 2018 | 110.65 Million USD | 3.12% |
| 2017 | 107.29 Million USD | 60.98% |
| 2016 | 66.65 Million USD | 134.04% |
| 2015 | 28.47 Million USD | 118.7% |
| 2014 | 13.02 Million USD | 36.5% |
| 2013 | 9.54 Million USD | 139.94% |
| 2012 | 3.97 Million USD | 167.56% |
| 2011 | 1.48 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.18 Billion USD | 1.65% |
| 2024 Q1 | 1.16 Billion USD | -4.01% |
| 2023 Q2 | 1.18 Billion USD | 1.66% |
| 2023 Q1 | 1.16 Billion USD | -2.52% |
| 2023 FY | 1.21 Billion USD | 1.9% |
| 2023 Q4 | 1.21 Billion USD | 0.76% |
| 2023 Q3 | 1.2 Billion USD | 2.04% |
| 2022 Q2 | 642.55 Million USD | 9.35% |
| 2022 Q3 | 1.14 Billion USD | 78.92% |
| 2022 FY | 1.19 Billion USD | 98.88% |
| 2022 Q4 | 1.19 Billion USD | 3.77% |
| 2022 Q1 | 587.6 Million USD | -2.04% |
| 2021 Q4 | 599.83 Million USD | 8.84% |
| 2021 Q3 | 551.12 Million USD | 2.01% |
| 2021 Q2 | 540.27 Million USD | -0.54% |
| 2021 FY | 599.83 Million USD | -0.88% |
| 2021 Q1 | 543.18 Million USD | -10.24% |
| 2020 Q1 | 623.99 Million USD | 29.53% |
| 2020 Q4 | 605.18 Million USD | 0.5% |
| 2020 Q3 | 602.19 Million USD | -2.63% |
| 2020 Q2 | 618.45 Million USD | -0.89% |
| 2020 FY | 605.18 Million USD | 25.63% |
| 2019 Q2 | 139.14 Million USD | 14.96% |
| 2019 FY | 481.73 Million USD | 335.37% |
| 2019 Q1 | 121.03 Million USD | 9.38% |
| 2019 Q3 | 152.67 Million USD | 9.73% |
| 2019 Q4 | 481.73 Million USD | 215.52% |
| 2018 Q1 | 93.69 Million USD | -12.68% |
| 2018 Q4 | 110.65 Million USD | 7.9% |
| 2018 FY | 110.65 Million USD | 3.12% |
| 2018 Q3 | 102.54 Million USD | 0.49% |
| 2018 Q2 | 102.05 Million USD | 8.92% |
| 2017 FY | 107.29 Million USD | 60.98% |
| 2017 Q2 | 68.08 Million USD | 18.74% |
| 2017 Q3 | 69.48 Million USD | 2.06% |
| 2017 Q1 | 57.34 Million USD | -13.97% |
| 2017 Q4 | 107.29 Million USD | 54.41% |
| 2016 Q1 | 34.36 Million USD | 20.65% |
| 2016 FY | 66.65 Million USD | 134.04% |
| 2016 Q2 | 38.05 Million USD | 10.76% |
| 2016 Q4 | 66.65 Million USD | 12.44% |
| 2016 Q3 | 59.27 Million USD | 55.76% |
| 2015 FY | 28.47 Million USD | 118.7% |
| 2015 Q4 | 28.47 Million USD | 12.27% |
| 2015 Q3 | 25.36 Million USD | 6.92% |
| 2015 Q2 | 23.72 Million USD | 61.17% |
| 2015 Q1 | 14.72 Million USD | 13.05% |
| 2014 Q1 | 6.99 Million USD | -26.7% |
| 2014 FY | 13.02 Million USD | 36.5% |
| 2014 Q4 | 13.02 Million USD | 12.21% |
| 2014 Q3 | 11.6 Million USD | 22.12% |
| 2014 Q2 | 9.5 Million USD | 35.89% |
| 2013 Q3 | 7.43 Million USD | 0.0% |
| 2013 FY | 9.54 Million USD | 139.94% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q4 | 9.54 Million USD | 28.26% |
| 2012 Q4 | 3.97 Million USD | 0.0% |
| 2012 FY | 3.97 Million USD | 167.56% |
| 2011 FY | 1.48 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Absci Corporation | 58.3 Million USD | -1984.932% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -244.503% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 69.989% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -37583.96% |
| Apollomics, Inc. | 14.15 Million USD | -8488.985% |
| 180 Life Sciences Corp. | 5.38 Million USD | -22464.541% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -23116.176% |
| Bicycle Therapeutics plc | 224.41 Million USD | -441.682% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -4318.593% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -833.568% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -2278.723% |
| Chimerix, Inc. | 19.74 Million USD | -6056.49% |
| CRISPR Therapeutics AG | 346.76 Million USD | -250.551% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -512.942% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -1267.978% |
| Fortress Biotech, Inc. | 165.93 Million USD | -632.558% |
| Fortress Biotech, Inc. | 165.93 Million USD | -632.558% |
| Gritstone bio, Inc. | 125.91 Million USD | -865.382% |
| Allakos Inc. | 74.79 Million USD | -1525.284% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -373.04% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -1667.913% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -0.41% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -8299.081% |
| Innoviva, Inc. | 568.55 Million USD | -113.806% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -172329.548% |
| NLS Pharmaceutics AG | 10.68 Million USD | -11281.796% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -4523.104% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -93462.241% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -9144.099% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -4840.254% |
| ImmuCell Corporation | 18.81 Million USD | -6360.789% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -4206.664% |
| Incyte Corporation | 1.59 Billion USD | 23.656% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -2086.514% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -300859.377% |
| Mustang Bio, Inc. | 17.61 Million USD | -6799.364% |
| MiMedx Group, Inc. | 96.33 Million USD | -1161.911% |
| MEI Pharma, Inc. | 8.35 Million USD | -14449.36% |
| MacroGenics, Inc. | 154.2 Million USD | -688.29% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -69070.584% |
| Mereo BioPharma Group plc | 15.96 Million USD | -7515.581% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -39433.629% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -688.618% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -74.263% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1324.117% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -19840.928% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -23971.267% |
| NextCure, Inc. | 14.99 Million USD | -8005.614% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -4374.213% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -29974.196% |
| Onconetix, Inc. | 23.18 Million USD | -5143.971% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -18105.766% |
| Opthea Limited | 264.6 Million USD | -359.408% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -2061.838% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -9942.373% |
| PDS Biotechnology Corporation | 33.25 Million USD | -3554.933% |
| Precigen, Inc. | 41.64 Million USD | -2819.026% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -10096.267% |
| Prime Medicine, Inc. | 60.78 Million USD | -1899.998% |
| PureTech Health plc | 125.58 Million USD | -867.965% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -1547.89% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 82.896% |
| Replimune Group, Inc. | 113.21 Million USD | -973.718% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -21744.064% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -733.35% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -34347.093% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -363.267% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -18297.876% |
| Sesen Bio, Inc. | 30.98 Million USD | -3823.312% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1374.651% |
| Solid Biosciences Inc. | 38.45 Million USD | -3060.848% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1971.432% |
| SciSparc Ltd. | 1.59 Million USD | -76113.103% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -278.589% |
| TG Therapeutics, Inc. | 169.08 Million USD | -618.928% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -2384.262% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -84082.756% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -106.698% |
| UroGen Pharma Ltd. | 243.52 Million USD | -399.172% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1865.907% |
| XOMA Corporation | 145.58 Million USD | -735.004% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -875.319% |
| AbCellera Biologics Inc. | 335.77 Million USD | -262.027% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -12337.068% |
| Cassava Sciences, Inc. | 14.19 Million USD | -8463.572% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -3355.653% |
| Precision BioSciences, Inc. | 140.92 Million USD | -762.616% |
| Dyadic International, Inc. | 2.34 Million USD | -51834.227% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -29312.025% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -7374.63% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -13482.112% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -3809.81% |
| IGM Biosciences, Inc. | 220.17 Million USD | -452.101% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -1164.155% |
| Acelyrin, Inc. | 86.35 Million USD | -1307.709% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -2371.935% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -830.018% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -34348.675% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -705.625% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -702.312% |
| Senti Biosciences, Inc. | 52.57 Million USD | -2212.3% |
| Mesoblast Limited | 188.79 Million USD | -543.862% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -572.389% |
| ChromaDex Corporation | 26.5 Million USD | -4485.782% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -14105.581% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -346.44% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -74769.858% |
| Seer, Inc. | 39.36 Million USD | -2988.02% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -249.732% |
| Novavax, Inc. | 2.57 Billion USD | 52.742% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -15699.262% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -782.147% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -6497.552% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -1178.542% |
| Celcuity Inc. | 51.45 Million USD | -2262.677% |
| ContextLogic Inc. | 206 Million USD | -490.097% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -149.814% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -1600.614% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 84.123% |
| Amarin Corporation plc | 279.58 Million USD | -334.784% |
| AnaptysBio, Inc. | 364.28 Million USD | -233.694% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -9531.559% |
| Aptorum Group Limited | 5.25 Million USD | -23024.588% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -63.116% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -154.102% |
| Ardelyx, Inc. | 130.76 Million USD | -829.62% |
| Celularity Inc. | 102.92 Million USD | -1081.007% |
| Omeros Corporation | 403.25 Million USD | -201.449% |
| Humacyte, Inc. | 114.67 Million USD | -960.02% |
| Immunocore Holdings plc | 228.15 Million USD | -432.788% |
| IO Biotech, Inc. | 17.55 Million USD | -6824.123% |
| GT Biopharma, Inc. | 6.63 Million USD | -18226.534% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -6865.385% |
| Summit Therapeutics Inc. | 125.25 Million USD | -870.484% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -62047.188% |
| Pulmatrix, Inc. | 15.96 Million USD | -7515.104% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -384.673% |
| Evogene Ltd. | 17.99 Million USD | -6657.082% |
| CorMedix Inc. | 11.91 Million USD | -10100.094% |
| BioLineRx Ltd. | 50.7 Million USD | -2297.537% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -12877.463% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -21399.805% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 55.337% |
| scPharmaceuticals Inc. | 57.26 Million USD | -2022.909% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -5302.422% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -958.773% |
| NLS Pharmaceutics AG | 10.68 Million USD | -11281.796% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -18297.876% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -2603.434% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -42255.366% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -17776.456% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -1667.45% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -6357.022% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -2500.824% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -9712.697% |
| Daré Bioscience, Inc. | 26.32 Million USD | -4516.809% |
| bluebird bio, Inc. | 424.62 Million USD | -186.277% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 35.684% |
| DBV Technologies S.A. | 42.8 Million USD | -2740.185% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -851.24% |
| Galecto, Inc. | 5.89 Million USD | -20517.351% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -12724.127% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -4330.51% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -359.775% |
| GlycoMimetics, Inc. | 6.9 Million USD | -17512.083% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -381.048% |
| ADMA Biologics, Inc. | 193.97 Million USD | -526.675% |
| Clene Inc. | 38.95 Million USD | -3020.842% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -538.905% |
| Aptose Biosciences Inc. | 15.8 Million USD | -7589.43% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -10911.174% |
| Soligenix, Inc. | 7.27 Million USD | -16609.485% |
| Century Therapeutics, Inc. | 175.94 Million USD | -590.913% |
| Kura Oncology, Inc. | 51.66 Million USD | -2252.985% |
| Surrozen, Inc. | 8.14 Million USD | -14824.481% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -902.291% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -18279.583% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -381.239% |
| Autolus Therapeutics plc | 263.9 Million USD | -360.616% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -11497.014% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -2491.951% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -1575.14% |
| GRI Bio, Inc. | 2.69 Million USD | -44972.265% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -150050.88% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -3271.232% |
| INmune Bio, Inc. | 18.86 Million USD | -6344.698% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -373.957% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -4462.749% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -44617.345% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -33793.551% |
| Jaguar Health, Inc. | 45.86 Million USD | -2550.327% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -36957.94% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1979.547% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -2334.606% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -359.176% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -47.698% |
| Verastem, Inc. | 71.18 Million USD | -1607.662% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -3051.016% |
| Histogen Inc. | 5.69 Million USD | -21237.529% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -27617.932% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -283.227% |
| Surrozen, Inc. | 8.14 Million USD | -14824.481% |
| Organovo Holdings, Inc. | 2.74 Million USD | -44135.771% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -387208.592% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -146911.217% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -859.242% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -11141.401% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -46522.1% |
| Kronos Bio, Inc. | 54.2 Million USD | -2142.761% |
| Turnstone Biologics Corp. | 14.14 Million USD | -8492.02% |
| Synaptogenix, Inc. | 5.52 Million USD | -21884.01% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -18185.184% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -435.903% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -614.604% |
| Exelixis, Inc. | 678.44 Million USD | -79.174% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -641.011% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -104.574% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -8182.904% |
| ESSA Pharma Inc. | 3.49 Million USD | -34680.381% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -23788.546% |
| Avid Bioservices, Inc. | 275.66 Million USD | -340.965% |
| Insmed Incorporated | 1.66 Billion USD | 26.849% |
| MediWound Ltd. | 27.18 Million USD | -4371.251% |
| OmniAb, Inc. | 87.4 Million USD | -1290.846% |
| Alector, Inc. | 487.66 Million USD | -149.267% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -201.297% |
| Zai Lab Limited | 240.17 Million USD | -406.126% |
| AlloVir, Inc. | 45.01 Million USD | -2600.431% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -92.934% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -3872.805% |
| Aura Biosciences, Inc. | 29.22 Million USD | -4059.164% |
| Immunic, Inc. | 25.36 Million USD | -4691.86% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -1655.733% |
| Veracyte, Inc. | 93.71 Million USD | -1197.068% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -46355.9% |
| FibroGen, Inc. | 585.72 Million USD | -107.536% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -6893.033% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1346.694% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -186034.386% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -21394.263% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -14727.995% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1346.763% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 53.575% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -4117.608% |
| XBiotech Inc. | 8.39 Million USD | -14376.587% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -8182.904% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -3114.85% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -8353.988% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -2185.82% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -234.778% |
| Agenus Inc. | 462.29 Million USD | -162.949% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -4421.645% |
| Theravance Biopharma, Inc. | 169 Million USD | -619.272% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -142.913% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -24.999% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -20055.487% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -832.658% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -327207.119% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -23485.408% |
| Lantern Pharma Inc. | 2.73 Million USD | -44270.077% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -2761.916% |
| Ainos, Inc. | 7.39 Million USD | -16339.848% |
| Pluri Inc. | 34.11 Million USD | -3463.552% |
| Prothena Corporation plc | 135.01 Million USD | -800.33% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -400.035% |
| Rallybio Corporation | 9.43 Million USD | -12782.567% |
| Kodiak Sciences Inc. | 213.59 Million USD | -469.125% |
| Cue Biopharma, Inc. | 24.44 Million USD | -4872.792% |
| MeiraGTx Holdings plc | 319.99 Million USD | -279.885% |
| Annexon, Inc. | 47.11 Million USD | -2479.904% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -1161.361% |
| Moderna, Inc. | 4.57 Billion USD | 73.412% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -24835.364% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1484.049% |
| Blueprint Medicines Corporation | 918.64 Million USD | -32.326% |
| Immix Biopharma, Inc. | 3.72 Million USD | -32561.738% |
| CalciMedica, Inc. | 4.02 Million USD | -30078.724% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -876.346% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1316.501% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -434.458% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -337.592% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -7606.834% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -2293.571% |
| Nutriband Inc. | 1.07 Million USD | -112568.236% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -11332.324% |
| Vor Biopharma Inc. | 59.1 Million USD | -1956.712% |
| Roivant Sciences Ltd. | 773.95 Million USD | -57.064% |
| Alkermes plc | 933.53 Million USD | -30.214% |
| ProKidney Corp. | 29.21 Million USD | -4060.73% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -1588.825% |
| Arcellx, Inc. | 339.75 Million USD | -257.79% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 35.646% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -713.333% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -1274.475% |
| Atai Life Sciences N.V. | 49.16 Million USD | -2372.639% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -3802.116% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -6667.615% |
| MediciNova, Inc. | 3.89 Million USD | -31136.861% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -6550.249% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -80711.452% |
| GeoVax Labs, Inc. | 3.51 Million USD | -34435.23% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -205.997% |
| Biomea Fusion, Inc. | 30.69 Million USD | -3860.896% |
| RenovoRx, Inc. | 4.46 Million USD | -27118.966% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -3796.026% |
| Geron Corporation | 146.12 Million USD | -731.878% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -6281.767% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -3691.401% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -1547.376% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1289.526% |
| Royalty Pharma plc | 6.29 Billion USD | 80.697% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -3499.642% |
| Imunon, Inc. | 8.53 Million USD | -14150.154% |
| BioAtla, Inc. | 48.98 Million USD | -2381.523% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -830.752% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -8451.523% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -542.644% |
| Structure Therapeutics Inc. | 29.05 Million USD | -4084.361% |
| 89bio, Inc. | 59.96 Million USD | -1927.248% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -3510.869% |
| aTyr Pharma, Inc. | 31.59 Million USD | -3747.198% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1866.257% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -2411.464% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -14800.666% |
| Akari Therapeutics, Plc | 4.58 Million USD | -26418.303% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -6754.96% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 26.303% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -791.731% |
| Liquidia Corporation | 73.13 Million USD | -1562.062% |
| Entera Bio Ltd. | 1.37 Million USD | -88050.761% |
| GH Research PLC | 6.7 Million USD | -18040.561% |
| Vericel Corporation | 127.7 Million USD | -851.881% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -3067.024% |
| Xencor, Inc. | 283.55 Million USD | -328.693% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -40614.378% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -44617.345% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -32254.5% |
| Vaxcyte, Inc. | 167.44 Million USD | -625.952% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -3196.361% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -1074.151% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -300859.377% |
| Portage Biotech Inc. | 4.45 Million USD | -27216.831% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -80711.452% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -5173.748% |
| OncoCyte Corporation | 49.29 Million USD | -2365.818% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -29284.972% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -152329.265% |
| Purple Biotech Ltd. | 10 Million USD | -12049.915% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -4794.701% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -18198.946% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -645.83% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -20909.316% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -9909.873% |
| United Therapeutics Corporation | 1.18 Billion USD | -2.825% |
| HilleVax, Inc. | 78.9 Million USD | -1440.507% |
| Silo Pharma, Inc. | 1.56 Million USD | -77362.706% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -90917.652% |
| Pharming Group N.V. | 244.07 Million USD | -398.047% |
| Tharimmune, Inc. | 1.81 Million USD | -66873.454% |
| Genprex, Inc. | 3.25 Million USD | -37254.68% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -5556.317% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -4382.462% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -2431.338% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -589996.602% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -338933.825% |
| OKYO Pharma Limited | 7.42 Million USD | -16280.868% |
| Savara Inc. | 37.19 Million USD | -3168.442% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -4089.554% |
| Curis, Inc. | 57.61 Million USD | -2009.975% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -3001.034% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -5738.892% |
| BeiGene, Ltd. | 2.23 Billion USD | 45.58% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -5614.012% |
| Erasca, Inc. | 78.61 Million USD | -1446.347% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -185416.259% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -185416.259% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -17278.113% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -73305.737% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -7021.26% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -3234.428% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -2084.954% |
| Adicet Bio, Inc. | 37.12 Million USD | -3174.782% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -96.792% |
| Aditxt, Inc. | 28.53 Million USD | -4160.542% |
| Adagene Inc. | 45.16 Million USD | -2591.204% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -672612.935% |
| Quantum-Si incorporated | 26.63 Million USD | -4464.601% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -39854.767% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -957.401% |
| Compugen Ltd. | 55.77 Million USD | -2079.469% |
| Generation Bio Co. | 171.63 Million USD | -608.267% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -10424.667% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -2805.976% |
| Invivyd, Inc. | 51.71 Million USD | -2250.664% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -1221.634% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -18586.427% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -1510.15% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -118959.647% |
| 2seventy bio, Inc. | 310.12 Million USD | -291.969% |
| Instil Bio, Inc. | 99.8 Million USD | -1118.023% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -3264.248% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -89095.886% |
| GeoVax Labs, Inc. | 3.51 Million USD | -34435.23% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -9880.564% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -9868.175% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -2200.484% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -228.67% |
| Evaxion Biotech A/S | 17.61 Million USD | -6799.96% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -655.364% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -693.544% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -5529.076% |
| Cingulate Inc. | 10.36 Million USD | -11632.601% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -44103.6% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -3159.678% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -4791.943% |
| Clearmind Medicine Inc. | 3.61 Million USD | -33573.028% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -2484.017% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -5241.008% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -5956.494% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -416.806% |
| ImmunityBio, Inc. | 1.09 Billion USD | -11.483% |
| Korro Bio, Inc. | 51.75 Million USD | -2248.893% |
| Kineta, Inc. | 7.22 Million USD | -16731.889% |
| BioVie Inc. | 9.7 Million USD | -12429.197% |
| Codexis, Inc. | 49.94 Million USD | -2333.827% |
| Celularity Inc. | 102.92 Million USD | -1081.007% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -981.503% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -1162.999% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -352049.516% |
| Cibus, Inc. | 206.11 Million USD | -489.762% |
| IN8bio, Inc. | 8.77 Million USD | -13757.718% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -1257.589% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -8780.115% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 53.307% |
| Eyenovia, Inc. | 19.78 Million USD | -6045.51% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -586.446% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -15726.051% |
| Elevation Oncology, Inc. | 34.28 Million USD | -3445.881% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -4944.189% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -10116.835% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -395.072% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -12611.482% |
| Moolec Science SA | 13.94 Million USD | -8616.873% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -2717.017% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -2305.602% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -2956.112% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -14480.772% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -412798.854% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -49308.93% |
| Humacyte, Inc. | 114.67 Million USD | -960.02% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -4493.58% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -101538.712% |
| Genelux Corporation | 8.42 Million USD | -14337.043% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -17630.44% |
| Notable Labs, Ltd. | 4.42 Million USD | -27358.753% |
| Immunovant, Inc. | 48.95 Million USD | -2383.095% |
| Quantum-Si incorporated | 26.63 Million USD | -4464.601% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -39074.96% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -1545.793% |
| Acasti Pharma Inc. | 11.55 Million USD | -10418.292% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -5276.918% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -5143.267% |
| PepGen Inc. | 34.63 Million USD | -3410.147% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -17305.484% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -14105.581% |
| Immuneering Corporation | 12 Million USD | -10022.944% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -387208.592% |
| Belite Bio, Inc | 4.21 Million USD | -28767.229% |
| XOMA Corporation | 145.58 Million USD | -735.004% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -49965.857% |
| Bionomics Limited | 10.15 Million USD | -11866.063% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -5205.281% |
| uniQure N.V. | 624.01 Million USD | -94.802% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -672612.935% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -614.285% |
| Forte Biosciences, Inc. | 3.66 Million USD | -33058.729% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -466392.058% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -17916.882% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -15726.051% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -6893.033% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -11402.64% |
| Altimmune, Inc. | 16.54 Million USD | -7249.006% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -24840.48% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -5205.281% |
| Peak Bio, Inc. | 20.75 Million USD | -5757.359% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -1000.458% |
| Benitec Biopharma Inc. | 4.96 Million USD | -24398.166% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -670.132% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -1517.047% |
| Zura Bio Limited | 21.29 Million USD | -5609.182% |
| PolyPid Ltd. | 17.46 Million USD | -6859.005% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -1517.047% |
| argenx SE | 444.95 Million USD | -173.198% |
| Immunome, Inc. | 28.65 Million USD | -4141.744% |
| Verona Pharma plc | 58.84 Million USD | -1965.905% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -8299.081% |
| Shattuck Labs, Inc. | 14.85 Million USD | -8080.894% |
| CervoMed Inc. | 2.59 Million USD | -46730.411% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -9444.59% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -11438.671% |
| Moolec Science SA | 13.94 Million USD | -8616.873% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -51771.002% |
| Design Therapeutics, Inc. | 11.95 Million USD | -10067.272% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -9483.72% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -3022.685% |
| Achilles Therapeutics plc | 19.08 Million USD | -6268.727% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -5241.008% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -8277.086% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -202.935% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -3643.415% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -9215.58% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -23041.043% |
| Beam Therapeutics Inc. | 478.38 Million USD | -154.105% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -205.464% |
| AEON Biopharma, Inc. | 159.88 Million USD | -660.277% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -4364.518% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -4582.404% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -15890.061% |
| NeurAxis, Inc. | 1.91 Million USD | -63452.79% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -521.034% |
| Lumos Pharma, Inc. | 13.33 Million USD | -9017.22% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -5053.466% |
| Palisade Bio, Inc. | 2.73 Million USD | -44281.124% |
| Nutriband Inc. | 1.07 Million USD | -112568.236% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -532.937% |
| Neurogene Inc. | 36.54 Million USD | -3225.943% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -49617.751% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -2451.1% |
| Athira Pharma, Inc. | 30.05 Million USD | -3944.312% |
| HCW Biologics Inc. | 15.05 Million USD | -7976.027% |
| XOMA Corporation | 145.58 Million USD | -735.004% |
| Nektar Therapeutics | 267.04 Million USD | -355.202% |
| Arvinas, Inc. | 644.6 Million USD | -88.582% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -6754.96% |
| Merus N.V. | 102.15 Million USD | -1090.002% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -730.611% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -1177.964% |
| Rezolute, Inc. | 11.73 Million USD | -10259.63% |
| Clene Inc. | 38.95 Million USD | -3020.842% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -42591.843% |
| BeyondSpring Inc. | 48.26 Million USD | -2418.384% |
| Synlogic, Inc. | 32.89 Million USD | -3595.391% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -8218.614% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -74294.064% |
| Peak Bio, Inc. | 20.75 Million USD | -5757.359% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1815.566% |
| Krystal Biotech, Inc. | 39.71 Million USD | -2960.883% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -222.745% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -1120.861% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -280816.562% |
| MannKind Corporation | 721.36 Million USD | -68.513% |
| Ikena Oncology, Inc. | 22.33 Million USD | -5342.574% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -58174.161% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -1084.91% |
| Gossamer Bio, Inc. | 249.14 Million USD | -387.904% |
| CohBar, Inc. | 1.03 Million USD | -117503.939% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -11272.43% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -6281.767% |
| Legend Biotech Corporation | 589.93 Million USD | -106.057% |
| Mural Oncology plc | 37.92 Million USD | -3105.017% |
| Disc Medicine, Inc. | 22.87 Million USD | -5214.094% |
| Champions Oncology, Inc. | 28.03 Million USD | -4236.005% |
| REGENXBIO Inc. | 262.22 Million USD | -363.566% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -36085.52% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -9598.412% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -8950.274% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -5632.606% |
| Vaxart, Inc. | 34.02 Million USD | -3472.664% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -5861.956% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -4160.494% |
| Cellectis S.A. | 249.57 Million USD | -387.068% |
| Longeveron Inc. | 5.33 Million USD | -22676.822% |
| Repare Therapeutics Inc. | 41.81 Million USD | -2806.81% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 49.46% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1913.648% |
| Revolution Medicines, Inc. | 262.39 Million USD | -363.267% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -57593.355% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -13992.268% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -10200.813% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -8556.263% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -56413.203% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 76.395% |
| Denali Therapeutics Inc. | 122.96 Million USD | -888.589% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -21744.064% |
| Veru Inc. | 32.81 Million USD | -3604.659% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -17596.885% |
| Cingulate Inc. | 10.36 Million USD | -11632.601% |
| Passage Bio, Inc. | 39.26 Million USD | -2996.121% |
| Context Therapeutics Inc. | 4.19 Million USD | -28900.039% |
| Exicure, Inc. | 8.54 Million USD | -14119.195% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -4019.557% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -11492.59% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -5415.172% |
| Nuvalent, Inc. | 31.82 Million USD | -3719.876% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -19008.304% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1828.849% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -6653.328% |
| OmniAb, Inc. | 87.4 Million USD | -1290.846% |
| Anew Medical, Inc. | 8.24 Million USD | -14649.195% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -3074.792% |
| Lipocine Inc. | 2.63 Million USD | -46091.883% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -4526.975% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -2922.976% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -4462.749% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1310.961% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -22406.925% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1369.055% |
| Ocugen, Inc. | 23.98 Million USD | -4968.586% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -2519.43% |
| Q32 Bio Inc. | 233.12 Million USD | -421.43% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -13308.328% |
| Alumis Inc. Common Stock | 53.5 Million USD | -2172.063% |
| Equillium, Inc. | 27.95 Million USD | -4248.102% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -488.406% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -21504.254% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -19720.73% |
| Dominari Holdings Inc. | 4.63 Million USD | -26126.516% |
| Edesa Biotech, Inc. | 1.84 Million USD | -65906.439% |
| vTv Therapeutics Inc. | 29.56 Million USD | -4011.337% |
| Bio-Techne Corporation | 744.34 Million USD | -63.312% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -864.004% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -252.904% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -2895.931% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -4097.945% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -1216.153% |
| Nkarta, Inc. | 105.6 Million USD | -1051.135% |
| BioCardia, Inc. | 4.59 Million USD | -26383.638% |
| Iterum Therapeutics plc | 32.66 Million USD | -3621.753% |